OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
91 hedge funds and large institutions have $301M invested in OptiNose in 2019 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 7 closing their positions.
200% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 7
67% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 21
52% more capital invested
Capital invested by funds: $199M → $301M (+$102M)
18% more funds holding
Funds holding: 77 → 91 (+14)
0.2% more ownership
Funds ownership: 4.57% → 4.77% (+0.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$10.2M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$7.78M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.71M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$5.57M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$11.8M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
-$1.46M |
| 3 |
WCM
Wildcat Capital Management
New York
|
-$1.1M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.04M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$871K |
OPTN Hedge Fund Activity: Q4 2019 in Review
91 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q4 2019, worth a combined $301M — up 52% from $199M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new OPTN positions and 7 closed out — a net gain of 14 holders — while 35 added to existing stakes and 21 trimmed.
The largest buyer was Great Point Partners, opening a new position worth an estimated $10.2M. The largest seller was Foresite Capital Management IV, cutting an estimated $11.8M.
- 91 institutional investors held OptiNose (OPTN) as of Q4 2019, up from 77 in Q3 2019.
- Funds reported $301M of OptiNose stock for Q4 2019, up 52% quarter-over-quarter.
- 21 funds opened new OptiNose positions in Q4 2019 and 7 closed out, a net change of +14 holders.
- The largest OptiNose buyer in Q4 2019 was Great Point Partners, an estimated $10.2M added.
- The largest OptiNose seller in Q4 2019 was Foresite Capital Management IV, an estimated $11.8M sold.
Based on aggregated 13F filings for Q4 2019.